Evaluating long-term treatments for prostate-related urinary issues using advanced analytics
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment
This study is looking at how well different medications work for men with enlarged prostates and urinary issues, and it aims to create personalized treatment plans using patient information to help improve their quality of life.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10848324 on NIH RePORTER |
What this research studies
This research focuses on understanding the long-term effectiveness of various pharmacological therapies for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). It aims to develop and validate clinical tools that personalize treatment options based on individual patient data. By utilizing machine learning and big data from electronic health records, the study seeks to identify which treatments work best for different patients over time. This approach not only addresses the limitations of current therapies but also aims to improve the quality of life for those affected by these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are older men experiencing symptoms related to benign prostatic hyperplasia.
Not a fit: Patients with prostate conditions unrelated to benign prostatic hyperplasia or those who do not experience lower urinary tract symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients suffering from BPH and LUTS.
How similar studies have performed: Previous research has shown promise in using machine learning to tailor treatments in other medical fields, suggesting potential success for this innovative approach in urology.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Langston, Marvin Epolian — Stanford University
- Study coordinator: Langston, Marvin Epolian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.